Press releases
2005
06-15-2005
Curasan Increases its Lead with New Clinical Data
Cerasorb ® ties with the gold standard in a multi-centre study
Kleinostheim, Germany, 15th June, 2005 – Cerasorb® synthetic bone regeneration material, produced by curasan AG, equals autogenous bone where therapy is concerned. This is the result of a prospective, randomised multi-centre study headed by Professor György Szabó, Budapest , Hungary and recently published in the renowned Journal of Oral and Maxillofacial Implants (JOMI, Vol. 20, 371-381, June 2005) ...05-12-2005
curasan AG announces results for first quarter
Improved earnings with lower revenue
Kleinostheim, May 12, 2005 – curasan AG (WKN 549 453) today announced its financial results for the first quarter ended March 31, 2005. In the first three months of the 2005 financial year, the company generated revenue of EUR 1.7 million (Q1 2004: EUR 2.4 million) and a loss before interest and taxes of EUR 400 thousand (Q1 2004: loss of EUR 516 thousand). The net loss for the period improved to EUR 256 thousand (Q1 2004: loss of EUR 335 thousand) ...